1. Home
  2. CD vs SGHT Comparison

CD vs SGHT Comparison

Compare CD & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chaince Digital Holdings Inc. Ordinary Shares

CD

Chaince Digital Holdings Inc. Ordinary Shares

HOLD

Current Price

$2.67

Market Cap

382.5M

Sector

Technology

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$7.52

Market Cap

309.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CD
SGHT
Founded
2011
2011
Country
United States
United States
Employees
13
N/A
Industry
Computer Software: Programming Data Processing
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
382.5M
309.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CD
SGHT
Price
$2.67
$7.52
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$9.08
AVG Volume (30 Days)
140.0K
175.4K
Earning Date
08-31-2023
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
$77,363,000.00
Revenue This Year
N/A
$11.67
Revenue Next Year
N/A
$10.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.73
$3.19
52 Week High
$14.10
$9.24

Technical Indicators

Market Signals
Indicator
CD
SGHT
Relative Strength Index (RSI) 38.24 78.53
Support Level $2.96 $6.56
Resistance Level $3.22 $8.93
Average True Range (ATR) 0.23 0.45
MACD 0.11 0.15
Stochastic Oscillator 56.52 97.10

Price Performance

Historical Comparison
CD
SGHT

About CD Chaince Digital Holdings Inc. Ordinary Shares

Chaince Digital Holdings Inc is digital fintech company providing access to the growing AI-powered infrastructure, blockchain, and digital assets. Its three core business lines include: blockchain and digital asset solutions, AI and HPC infrastructure, developing liquid cooling solutions for AI data centers and comprehensive financial services through Chaince Securities,LLC a FINRA-registered broker-dealer, and RIA.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: